Skip to content
Home

Antibody (Immunoglobulin): Structure, Function and Medical Uses

Antibodies are Y-shaped proteins of the adaptive immune system that recognize antigens. This article explains their structure, how they are produced, their roles, applications, and important distinctions.

Author: Created: Updated:

Overview

Antibodies, also known as immunoglobulins, are specialized Y-shaped proteins produced by the immune system of vertebrates. They circulate in blood and other body fluids and are central to the adaptive immune system. By binding specifically to portions of foreign molecules called antigens, antibodies help identify and control invading organisms such as bacteria and viruses.

Image gallery

9 Images
AngeloftheWest
en.wikipedia.org · CC BY-SA 3.0

Structure and diversity

All antibodies share a common basic shape: two identical heavy chains paired with two identical light chains form the characteristic Y configuration. Each arm of the Y contains a variable region that recognizes a particular antigen and a constant region that mediates interaction with other immune components. The variable tips are extremely diverse, enabling a vast repertoire of antigen-binding sites. This molecular diversity is the reason one antibody will bind one specific target but not another: for example, antibodies developed against smallpox will not neutralize unrelated pathogens such as the bubonic plague or the common cold.

How antibodies are produced

Antibodies are generated by B lymphocytes. When a B cell encounters its matching antigen, it can differentiate into a plasma cell that secretes large quantities of antibody with the same specificity. The immune system increases diversity and improves affinity through genetic processes that alter antibody genes in developing B cells. These mechanisms produce a highly adaptable system able to recognize many different antigens across the class of vertebrates.

Functions and applications

Antibodies serve several complementary roles in immunity and medicine. They can directly neutralize toxins or viruses by blocking essential interactions, tag microbes or infected cells to promote engulfment by phagocytes, and recruit other immune functions such as complement activation. In practical and clinical contexts, antibodies are the basis of:

  • therapeutic biologics (monoclonal antibodies used to treat cancers, autoimmune diseases and infections),
  • diagnostic tests (ELISA, rapid antigen tests and laboratory immunoassays),
  • vaccine strategies that stimulate protective antibody responses, and
  • passive immunotherapies using pooled immune globulins to provide immediate but temporary protection.

History and development

The existence and protective effects of antibodies were recognized in the late 19th and early 20th centuries during experiments with antitoxins and serum therapy. Over the following decades research clarified their protein nature, molecular structure and genetic basis. The development of monoclonal antibody technology in the 20th century transformed both research and clinical treatment by enabling production of uniform, high-affinity antibodies for specific targets.

Notable distinctions and facts

Different antibody classes have specialized roles: some predominate in circulation, others in mucosal secretions or allergic responses. Antibody specificity can display cross-reactivity when similar antigens are recognized, which can be useful or problematic depending on context. Maternal antibodies transferred before birth or through breastfeeding provide early-life protection until an infant's own immune system matures. At a practical level, antibody-based tools remain indispensable in research, diagnostics and therapeutics because of their combination of specificity and functional versatility. For further technical background and resources, see introductory material on antigens and immune responses through linked resources above.

bacteria · blood · vertebrates · adaptive immune system · antigen · humoral immunity · virus · smallpox · bubonic plague

IgG sculpture Angel of the West by Julian Voss-Andreae in front of the Scripps Research Institute in Jupiter, Florida. The sculpture places the main chain (using the structure published by E. Padlan) in a ring instead of a human like Leonardo da Vinci's Vitruvian Man to show the similarity between antibodies and the human body.
IgG sculpture Angel of the West by Julian Voss-Andreae in front of the Scripps Research Institute in Jupiter, Florida. The sculpture places the main chain (using the structure published by E. Padlan) in a ring instead of a human like Leonardo da Vinci's Vitruvian Man to show the similarity between antibodies and the human body.

Structure of antibodies

Since some amino acid residues carry sugar chains, antibodies belong to the group of glycoproteins. Each antibody consists of two identical heavy chains (H) and two identical light chains (L), which are linked to each other by covalent disulfide bridges between the chains (so-called interchain disulfides) to form a ypsilon-shaped structure. The light chains (also: light chains) each consist of one variable and one constant domain. They are referred to as VL and CL. The heavy chains (also known as heavy chains), on the other hand, each have one variable and three (IgG, IgA) or four (IgM, IgE) constant domains. These are designated analogously as VH and CH1, CH2, CH3.

The variable domains of a light and a heavy chain together form the antigen binding site. The constant domain CH2 also consists of, among other things, a carbohydrate chain that forms a binding site for the complement system. The constant domain CH3 is the Fc receptor binding site for opsonization. The variable domains in turn form various characteristic paratopes, which together form an idiotype.

The two light chains are either of type κ or λ, depending on the organism and immunoglobulin subclass, and together with the portion of the heavy chains above the hinge region form the antigen-binding fragment Fab, which can be enzymatically cleaved from the underlying crystallisable fragment Fc with the aid of papain. The organism achieves the exceptional variability of the antigen binding sites (complementarity determining region, CDR) by means of V(D)J recombination.

Papain cleaves above the interchain disulfide bridges of the two heavy chains to each other. Thus, two Fab fragments and one complete fragment Fc are obtained. Pepsin, on the other hand, cleaves below the disulfide bridges. The hinge region remains between the two Fab fragments. This fragment is then called F(ab)2. Pepsin and plasmin also cleave the Fc fragment between the second and third domains of the constant part of the heavy chain.

Structure of a typical IgG antibody1 . Fab section2 . Fc section3 . Heavy chains4 . Light chains5 . Antigen binding site (paratope) 6. hinge region (*) -S-S-disulfide bridge
Structure of a typical IgG antibody1 . Fab section2 . Fc section3 . Heavy chains4 . Light chains5 . Antigen binding site (paratope) 6. hinge region (*) -S-S-disulfide bridge
Antibody digested with papain (two 50-kDa Fab fragments and one 50-kDa Fc fragment)
Antibody digested with papain (two 50-kDa Fab fragments and one 50-kDa Fc fragment)

Antigen - antibody - binding

Antibodies bind "their" paratope relatively specifically with their A(ntigen)B(inding) region, analogous to the lock-and-key principle. However, it is not uncommon that, metaphorically speaking, a second or third key exists that fits into the antibody "lock" due to the (coincidentally) similar or identical configuration of the epitope. With very low probability, this may also be an endogenous structure. One approach to explaining autoimmune diseases is based on this phenomenon.

The binding between epitope and immunoglobulin is non-covalent and subject to the law of mass action. Effective agglutination, i.e. agglutination through the formation of large complexes, is therefore only possible with approximately the same number of epitopes and binding sites. In the case of large deviations upwards or downwards, the complexes remain in solution; nevertheless, neutralisation of the effect of the antigens usually occurs. Neutralizing antibodies effective against several virus strains are called broadly neutralizing antibodies, e.g. broadly neutralizing anti-HIV antibodies.

Questions and answers

Q: What are antibodies?

A: Antibodies are large Y-shaped proteins that can stick to the surface of bacteria and viruses. They are found in the blood or other body fluids of vertebrates, and they play a key role in the adaptive immune system.

Q: How do antibodies work?

A: Each tip of the "Y" of an antibody contains a structure (like a lock) that fits one particular key-like structure on an antigen. This binds the two structures together, allowing them to tag microbes or infected cells for attack by other parts of the immune system, or to directly neutralize their target.

Q: What is humoral immunity?

A: Humoral immunity is when antibodies are produced in response to foreign antigens entering the body. It is part of the adaptive immune system which helps protect against disease and infection.

Q: Are all antibodies different?

A: Yes, each antibody is designed to attack only one kind of antigen (in practice, this means virus or bacteria). For instance, an antibody designed to destroy smallpox is unable to hit the bubonic plague or the common cold. Though they have a similar general structure, there is variation at their tips which allows millions of different variants with different tip structures to exist so that they can bind with different antigens.

Q: How does this diversity help our bodies?

A: This enormous diversity of antibodies allows our immune systems to recognize an equally wide variety of antigens so that it can better protect us from disease and infection.

Q: Where do we find antibodies?

A: Antibodies are found in the blood or other body fluids of vertebrates such as humans and animals.

Related articles

Author

AlegsaOnline.com Antibody (Immunoglobulin): Structure, Function and Medical Uses

URL: https://en.alegsaonline.com/art/4627

Share

Sources